Filing Details

Accession Number:
0001555667-16-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-09 20:50:14
Reporting Period:
2016-03-08
Filing Date:
2016-03-09
Accepted Time:
2016-03-09 20:50:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311230 Solazyme Inc SZYM Industrial Organic Chemicals (2860) 331077078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514853 Tyler Painter Solazyme, Inc.
225 Gateway Boulevard
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-03-08 1,562 $1.66 367,523 No 4 S Direct
Common Stock Acquisiton 2016-03-08 50,000 $0.00 417,523 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2016-03-08 275,000 $0.00 275,000 $1.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
275,000 2026-03-07 No 4 A Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.63 to $1.69, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 2,500 shares acquired under the Solazyme Employee Stock Purchase Plan.
  4. The grant shall vest as to 1/4 of the shares on March 9, 2017 and thereafter shall vest as to 1/8 of the shares on each of September 14, 2017, March 8, 2018, September 14, 2018, March 1, 2019, September 11, 2019 and March 11, 2020.
  5. The option shall vest as to 1/48 of the underlying shares monthly beginning February 1, 2016.